All lobbying filings
FORWARD GLOBAL
Lobbying for QUOIN PHARMACEUTICALS, INC. · Development and commercialization of therapeutic drug products that treat rare diseases.
Filing
2nd Quarter - Report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Income
$20,000.00
What the client paid this registrant for the period.
Client based in
Virginia
Government bodies contacted
2
Lobbying activity
1
Advocating for robust support of the rare disease community at large, including continued government funding for rare disease research and development, clinical trial reform to accelerate the path to new treatments, and financial incentives such as the Rare Pediatric Disease Designation and Priority Review Voucher Programs that encourage investment in this space.